GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OpGen Inc (OTCPK:OPGN) » Definitions » Pretax Margin %

OpGen (OPGN) Pretax Margin % : % (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is OpGen Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. OpGen's Pre-Tax Income for the three months ended in Sep. 2024 was $8.93 Mil. OpGen's Revenue for the three months ended in Sep. 2024 was $0.00 Mil. Therefore, OpGen's pretax margin for the quarter that ended in Sep. 2024 was %.

The historical rank and industry rank for OpGen's Pretax Margin % or its related term are showing as below:

OPGN' s Pretax Margin % Range Over the Past 10 Years
Min: -1430.11   Med: -516.87   Max: -137.45
Current: -742.42


OPGN's Pretax Margin % is ranked worse than
91.6% of 821 companies
in the Medical Devices & Instruments industry
Industry Median: -1.13 vs OPGN: -742.42

OpGen Pretax Margin % Historical Data

The historical data trend for OpGen's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OpGen Pretax Margin % Chart

OpGen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -355.70 -618.84 -807.29 -1,430.11 -955.79

OpGen Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -581.26 -1,592.71 171.43 -5,628.57 -

Competitive Comparison of OpGen's Pretax Margin %

For the Medical Devices subindustry, OpGen's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OpGen's Pretax Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OpGen's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where OpGen's Pretax Margin % falls into.



OpGen Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

OpGen's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-32.669/3.418
=-955.79 %

OpGen's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=8.931/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OpGen  (OTCPK:OPGN) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


OpGen Pretax Margin % Related Terms

Thank you for viewing the detailed overview of OpGen's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


OpGen Business Description

Traded in Other Exchanges
Address
9717 Key West Avenue, Suite 100, Rockville, MD, USA, 20850
OpGen Inc is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It is developing molecular information products and services for healthcare settings, helping to guide clinicians with rapid and actionable information about life-threatening infections, improve patient outcomes, and decrease the spread of infections caused by MDROs. Its proprietary DNA tests and informatics address the rising threat of antibiotic resistance by helping physicians and other healthcare providers optimize care decisions for patients with acute infections. The company's product candidates and services combine its Acuitas molecular diagnostics and Acuitas Lighthouse informatics platform for use with its curated MDRO knowledge base.
Executives
Yvonne Schlaeppi director 600 EAST GREENWICH AVENUE, WEST WARWICK X1 02893
Johannes Bacher officer: Chief Operating Officer 9717 KEY WEST AVENUE, SUITE 101, ROCKVILLE MD 20850
Albert Weber officer: Chief Finanical Officer MARIENBURGER STR. 7, BERLIN 2M 10405
Oliver Schacht director, officer: Chief Executive Officer 9717 KEY WEST AVENUE, SUITE 101, ROCKVILLE MD 20850
Evan/ Fa Jones director, officer: Chief Executive Officer C/O OPGEN, INC., 708 QUINCE ORCHARD ROAD, SUITE 205, GAITHERSBURG MD 20878
William E. Rhodes director C/O OPGEN, INC., 9717 KEY WEST AVE., SUITE 100, ROCKVILLE MD 20850
Curetis N.v. In Liquidation 10 percent owner MAX-EYTH-STRASSE 42, HOLZGERLINGEN 2M 71088
Mario Crovetto director C/O OPGEN, INC., 9717 KEY WEST AVE., SUITE 100, ROCKVILLE MD 20850
Prabhavathi Fernandes director 114 MILTON AVENUE, CHAPEL HILL NC 27514
Vadim M. Sapiro officer: Chief Information Officer C/O OPGEN, INC,, 708 QUINCE ORCHARD ROAD, SUITE 205, GAITHERSBURG MD 20878
Timothy C Dec officer: Chief Financial Officer C/O OPGEN, INC., 708 QUINCE ORCHARD ROAD, SUITE 205, GAITHERSBURG MD 20878
R Don Elsey director 2273 RESEARCH BLVD, SUITE 400, ROCKVILLE MD 20850
Jven Capital, Llc 10 percent owner P.O. BOX 60207, POTOMAC MD 20859
Tina Susan Nova director C/O ARENA PHARMACEUTICALS, INC., 6166 NANCY RIDGE DRIVE, SAN DIEGO CA 92121
Harry J D'andrea director 6480 DOBBIN ROAD, COLUMBIA MD 21045

OpGen Headlines

From GuruFocus

Q1 2023 OpGen Inc Earnings Call Transcript

By GuruFocus Research 02-08-2024

Q4 2020 OpGen Inc Earnings Call Transcript

By GuruFocus Research 02-08-2024

Q1 2021 OpGen Inc Earnings Call Transcript

By GuruFocus Research 02-08-2024

Q2 2021 OpGen Inc Earnings Call Transcript

By GuruFocus Research 02-08-2024

Q4 2021 OpGen Inc Earnings Call Transcript

By GuruFocus Research 02-08-2024

Q3 2021 OpGen Inc Earnings Call Transcript

By GuruFocus Research 02-08-2024

Q1 2019 OpGen Inc Earnings Call Transcript

By GuruFocus Research 02-08-2024

Q3 2022 OpGen Inc Earnings Call Transcript

By GuruFocus Research 02-08-2024